IL1B and neurodegenerative disease: The link between IL-1β and neurodegeneration has been validated through clinical studies showing that patients with neurodegenerative diseases exhibit higher IL-1β levels than healthy controls, which are associated with exacerbated CNS immune reactions and greater disease severity (53, 54).